Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Robert L Giuntoli"'
Autor:
Daniel H. Saris, Anna Jo Bodurtha Smith, Colleen Brensinger, Sarah H. Kim, Ashley F. Haggerty, Nawar Latif, Lori Cory, Robert L. Giuntoli, Mark A. Morgan, Lilie L. Lin, Emily M. Ko
Publikováno v:
Gynecologic Oncology Reports, Vol 40, Iss , Pp 100922- (2022)
Objectives: To examine overall survival (OS) and cancer-specific survival (CSS) for different racial groups of women with surgically staged endometrial cancer by histologic subtype. Methods: This is a retrospective cohort study of women with stage I-
Externí odkaz:
https://doaj.org/article/9b56877f403f46559c5972e8eef9533b
Autor:
Lori Cory, Colleen Brensinger, Robert A. Burger, Robert L. Giuntoli, II, Mark A. Morgan, Nawar Latif, Lilie L. Lin, Emily M. Ko
Publikováno v:
Gynecologic Oncology Reports, Vol 39, Iss , Pp 100930- (2022)
Objective: To determine patterns in type and sequence of adjuvant treatment and associated differences in overall survival among women with Stage I uterine carcinosarcoma (UCS). Methods: Women with stage I UCS from 2000 to 2015 were identified throug
Externí odkaz:
https://doaj.org/article/27e6afd940c3429fbbf4c79c10e05e95
Autor:
Dimitrios Nasioudis, Emily M. Ko, Ashley F. Haggerty, Robert L. Giuntoli, II, Robert A. Burger, Mark A. Morgan, Nawar A. Latif
Publikováno v:
Gynecologic Oncology Reports, Vol 28, Iss , Pp 86-90 (2019)
Abstact: Objective: To evaluate the prognostic significance of isolated distant lymph node metastases in comparison to other metastatic sites and stage IIIC disease. Methods: The National Cancer Data Base was accessed and patients diagnosed between 2
Externí odkaz:
https://doaj.org/article/f14a9bdd7c8f461183cd05b5a7497417
Autor:
Dimitrios Nasioudis, Emily M. Ko, Ashley F. Haggerty, Robert L. Giuntoli, II, Robert A. Burger, Mark A. Morgan, Nawar A. Latif
Publikováno v:
Gynecologic Oncology Reports, Vol 28, Iss , Pp 145-148 (2019)
Objective: The aim of the present study was to investigate the patterns of use and prognostic significance of adjuvant chemotherapy (CT) for patients with stage IC ovarian granulosa cell tumors (GCTs). Methods: We identified patients with stage IC GC
Externí odkaz:
https://doaj.org/article/d7279204f4cd4397ba2d1a935e9a0b5b
Autor:
Dimitrios, Nasioudis, Nawar A, Latif, Emily M, Ko, Lori, Cory, Sarah H, Kim, Fiona, Simpkins, Mark A, Morgan, Robert L, Giuntoli
Publikováno v:
Gynecologic Oncology. 169:41-46
Investigate outcomes for advanced stage epithelial ovarian cancer (EOC) patients based on facility-level utilization of neoadjuvant chemotherapy (NACT).Stage III-IV EOC patients diagnosed between 2010 and 2016 were identified in the National Cancer D
Autor:
Dimitrios, Nasioudis, Neil K, Taunk, Emily M, Ko, Ashley F, Haggerty, Lori, Cory, Robert L, Giuntoli, Sarah H, Kim, Nawar A, Latif
Publikováno v:
American Journal of Clinical Oncology. 45:373-378
Evaluate whether the addition of external beam radiation (EBRT) to adjuvant chemotherapy with or without vaginal brachytherapy is associated with better survival for patients with stage IIIC endometrioid endometrial carcinoma.Patients diagnosed betwe
Autor:
Dimitrios Nasioudis, Spyridon A Mastroyannis, Emily M Ko, Ashley F Haggerty, Lori Cory, Robert L Giuntoli, Sarah H Kim, Nawar A Latif
Publikováno v:
International Journal of Gynecologic Cancer. 32:1355-1360
ObjectiveTo investigate the utilization and outcomes of ovarian preservation for premenopausal patients with International Federation of Gynecology and Obstetrics (FIGO) stage I grade 2 and 3 endometrioid endometrial carcinoma undergoing hysterectomy
Autor:
Tonya J. Webb, Jonathan P. Schneck, Mathias Oelke, Robert L. Giuntoli, Simeon E. Goldblum, Sarah Spiegel, Sarah M. Temkin, Irina V. Tiper
The source of GD3 impacts CD1d-mediated antigen presentation.(A) LCD1d cells were treated with GD3 from different sources for 4 hours, then washed extensively and cocultured with NKT cell hybridomas. IL-2 was measured, as an indication of NKT cell ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799e58147807faa82cbcc2187827ae44
https://doi.org/10.1158/1078-0432.22455872.v1
https://doi.org/10.1158/1078-0432.22455872.v1
Autor:
Tonya J. Webb, Jonathan P. Schneck, Mathias Oelke, Robert L. Giuntoli, Simeon E. Goldblum, Sarah Spiegel, Sarah M. Temkin, Irina V. Tiper
Ovarian cancer associated ascites contains soluble inhibitory factors. The ascites was cleared of cellular debris by centrifugation as previously described (18). (A, B) The ascites was filtered 0.2 micron filter and fractionated- f1: 50. (C) The asci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::280df69edd902461d357cb0ed0f9abe5
https://doi.org/10.1158/1078-0432.22455875.v1
https://doi.org/10.1158/1078-0432.22455875.v1
Autor:
Jonathan P. Schneck, Mathias Oelke, Christian Kurts, Moriya Tsuji, Ronald L. Schnaar, Christoph Heuser, Pablo H.H. Lopez, Robert L. Giuntoli, Xiangming Li, Tonya J. Webb
PDF file - 225K, Schematic of Ganglioside GD3 and other glycolipids used or referred to in this paper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80a16e1f594710df302e177cd90b1c77
https://doi.org/10.1158/0008-5472.22392759.v1
https://doi.org/10.1158/0008-5472.22392759.v1